The peri-operative management of anti-platelet therapy in elective, non-cardiac surgery

被引:5
|
作者
Alcock, Richard F. [1 ]
Naoum, Chris [1 ]
Aliprandi-Costa, Bernadette [1 ]
Hillis, Graham S. [1 ]
Brieger, David B. [1 ]
机构
[1] Univ Sydney, Concord Repatriat Gen Hosp, Dept Cardiol, Sydney, NSW 2006, Australia
关键词
Peri-operative; Anti-platelet therapy; Elective non-cardiac surgery; CORONARY-ARTERY-DISEASE; CARDIAC RISK; MYOCARDIAL-INFARCTION; VASCULAR-SURGERY; ASPIRIN; MORTALITY; VALIDATION; PREDICTORS; PREVENTION; GUIDELINES;
D O I
10.1016/j.ijcard.2011.12.096
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cardiovascular complications are important causes of morbidity and mortality in patients undergoing elective non-cardiac surgery, with adverse cardiac outcomes estimated to occur in approximately 4% of all patients. Anti-platelet therapy withdrawal may precede up to 10% of acute cardiovascular syndromes, with withdrawal in the peri-operative setting incompletely appraised. Objectives: The aims of our study were to determine the proportion of patients undergoing elective noncardiac surgery currently prescribed anti-platelet therapy, and identify current practice in peri-operative management. In addition, the relationship between management of anti-platelet therapy and perioperative cardiac risk was assessed. Methods: We evaluated consecutive patients attending elective non-cardiac surgery at a major tertiary referral centre. Clinical and biochemical data were collected and analysed on patients currently prescribed antiplatelet therapy. Peri-operative management of anti-platelet therapy was compared with estimated perioperative cardiac risk. Results: Included were 2950 consecutive patients, with 516 (17%) prescribed anti-platelet therapy, primarily for ischaemic heart disease. Two hundred and eighty nine (56%) patients had all anti-platelet therapy ceased in the peri-operative period, including 49% of patients with ischaemic heart disease and 46% of patients with previous coronary stenting. Peri-operative cardiac risk score did not influence anti-platelet therapy management. Conclusions: Approximately 17% of patients undergoing elective non-cardiac surgery are prescribed anti-platelet therapy, the predominant indication being for ischaemic heart disease. Almost half of all patients with previous coronary stenting had no anti-platelet therapy during the peri-operative period. The decision to cease antiplatelet therapy, which occurred commonly, did not appear to be guided by peri-operative cardiac risk stratification. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:374 / 377
页数:4
相关论文
共 50 条
  • [11] Assessment and Management of Ischaemic Heart Disease in Non-Cardiac Surgery
    Morgan, Holly
    Ezad, Saad M.
    Rahman, Haseeb
    De Silva, Kalpa
    Partridge, Judith S. L.
    Perera, Divaka
    HEART INTERNATIONAL, 2023, 17 (02): : 19 - 26
  • [12] Potential risks of non-cardiac peri-operative myocardial infarction/injury
    Thygesen, Kristian
    Jaffe, Allan S.
    EUROPEAN HEART JOURNAL, 2023, 44 (19) : 1702 - 1704
  • [13] Management of peri-operative anti-thrombotic therapy
    van Veen, J. J.
    Makris, M.
    ANAESTHESIA, 2015, 70
  • [14] Elective non-cardiac surgery in patients with underlying cardiac disease. Preoperative risk assessment and perioperative approach
    Markworth, F.
    Debus, E. S.
    Blankenberg, S.
    GEFASSCHIRURGIE, 2013, 18 (01): : 21 - 27
  • [15] NT-proBNP incorporated in prediction rule of major peri-operative adverse cardiac event in non-cardiac surgery
    Truong Quang Binh
    Do Van Trang
    Nguyen Lam Vuong
    Nguyen Van Khoi
    Elfaituri, Muhammed Khaled
    Tran Thai Huu Loc
    Kamel, Mohamed Gomaa
    Le Huu Nhat Minh
    Nguyen Tien Huy
    SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2019, 17 (03): : 127 - 132
  • [16] Pre-Operative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-Cardiac Surgery
    Barbarash, L. S.
    Sumin, A. N.
    Barbarash, O. L.
    Ivanov, S. V.
    KARDIOLOGIYA, 2012, 52 (05) : 77 - 87
  • [17] Evaluation of the use of anti-platelet therapy throughout the peri-operative period in patients with femoral neck fracture surgery. A retrospective cohort study
    Ahmed Kamel Abdulhamid
    International Orthopaedics, 2020, 44 : 1805 - 1813
  • [18] Peri-operative Takotsubo syndrome after non-cardiac surgery: a retrospective nested case-control study
    Shang, Zhi
    Zhao, Menglin
    Cai, Jiageng
    Wu, Cencen
    Xu, Yuan
    Zeng, Lin
    Cai, Hong
    Xu, Mao
    Fan, Yuanyuan
    Li, Yanguang
    Gao, Wei
    Xu, Weixian
    Zu, Lingyun
    ESC HEART FAILURE, 2022, 9 (05): : 3149 - 3159
  • [19] Prospective comparison of three methods for detecting peri-operative neurocognitive disorders in older adults undergoing cardiac and non-cardiac surgery
    van Zuylen, M. L.
    Kampman, J. M.
    Turgman, O.
    Gribnau, A.
    ten Hoope, W.
    Preckel, B.
    Willems, H. C.
    Geurtsen, G. J.
    Hermanides, J.
    ANAESTHESIA, 2023, 78 (05) : 577 - 586
  • [20] How Long After Coronary Artery Bypass Surgery Can Patients Have Elective Safer Non-Cardiac Surgery?
    Sung, Li-Chin
    Chang, Chuen-Chau
    Yeh, Chun-Chieh
    Cherng, Yih-Giun
    Chen, Ta-Liang
    Liao, Chien-Chang
    JOURNAL OF MULTIDISCIPLINARY HEALTHCARE, 2024, 17 : 743 - 752